Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- average time wearing the accelerometer, in hours
研究概览
简要总结
Pancreatic cancer is the 5th leading cause of death from cancer in France. When chemotherapy can be proposed, the choice of treatment is currently based on the patient's profile and expected tolerance. The endpoints currently used in trials, such as time to therapeutic failure, do not take into account the patient's experience of the disease. The use of quality of life questionnaires is often proposed, but frequent missing data and filling time can be a problem. In oncology, some studies have demonstrated, through questionnaires, the link between physical activity and quality of life. In this situation, ambulatory measurement of physical activity by wrist actimetry could be an integrative reflection of the impact of the disease and treatment (efficacy, tolerance) on patients. This type of evaluation, if accepted by patients, could usefully complement the measurement of quality of life in this population. No study has specifically looked at the use of devices of this type in the context of digestive cancer. The investigators propose to evaluate the acceptance of this type of device by pancreatic cancer patients receiving chemotherapy before evaluating its potential interest.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with unresectable pancreatic adenocarcinoma for whom an indication for chemotherapy has been decided upon after a multidisciplinary consultation meeting;
- •Adult patient;
- •Patients able to understand spoken and written French,
- •Patient has given consent.
排除标准
- •WHO ECOG stage III or IV ;
- •Patient suffering from a major physical disability (hemiplegia, paraplegia, myopathy, amputation of a limb);
- •Any alteration of comprehension capacities making self-evaluation impossible;
- •Protected adult;
- •Patient not affiliated to a national health insurance scheme;
- •Pregnant or nursing women.
结局指标
主要结局
average time wearing the accelerometer, in hours
时间窗: every 2 weeks for 6 months
the amount of time the accelerometer is not worn will be estimated using the standard deviation and range of acceleration in each of the 3 axes, calculated for consecutive 15-minute windows
次要结局
未报告次要终点
